Anti-epileptic Keppra Could Be Candidate for Treatment of SMA, Study Finds

The anti-epileptic medicine Keppra (levetiracetam) may have a neuroprotective effect for spinal muscular atrophy (SMA), according to a recent study. The study, “The Protective Effects of Levetiracetam on a Human iPSCs‑Derived Spinal Muscular Atrophy Model,” was published in the journal Neurochemical Research. Spinal muscular atrophy (SMA) is characterized…